Neuroendocrine disorder in chronic fatigue syndrome.
Tomic, Slavica, Brkic, Snezana, Lendak, Dajana et al. · Turkish journal of medical sciences · 2017 · DOI
Quick Summary
This study looked at hormone levels in 40 women with ME/CFS compared to 40 healthy women to see if hormonal imbalances might explain ME/CFS symptoms. While standard hormone tests showed mostly normal results, researchers found that cortisol (a stress hormone) didn't follow its natural daily rhythm in ME/CFS patients the way it does in healthy people, and thyroid hormone T3 was lower in the ME/CFS group. The findings suggest that ME/CFS may involve subtle disruptions in how the body regulates these hormones over time.
Why It Matters
This research supports the hypothesis that ME/CFS involves neuroendocrine dysfunction, which is a leading biological explanation for the condition. Identifying disrupted cortisol rhythms as a potential biomarker could improve diagnosis and help researchers develop targeted treatments. Understanding these hormonal patterns may also validate the biological basis of ME/CFS for patients and clinicians.
Observed Findings
Normal absolute cortisol, ACTH, T4, and TSH levels in both CFS and healthy groups.
Absence of positive correlation between morning and afternoon cortisol levels in CFS patients, whereas healthy controls showed this expected correlation.
Significantly lower serum T3 concentrations in the CFS group despite normal T4 and TSH.
Disturbed diurnal rhythm of cortisol secretion in CFS patients compared to controls.
Inferred Conclusions
HPA axis dysfunction in CFS may not be detectable by single-point hormone measurements alone.
Disrupted cortisol circadian rhythm (loss of correlation between morning and afternoon levels) may be a more sensitive marker of HPA axis disturbance than absolute hormone values.
Subtle neuroendocrine abnormalities in CFS warrant investigation of dynamic hormone patterns rather than static measurements.
Remaining Questions
Would repeated sampling across multiple days or dynamic testing (such as dexamethasone suppression or TRH stimulation tests) reveal more pronounced hormonal abnormalities?
Is the disrupted cortisol rhythm a cause or consequence of ME/CFS, and does it correlate with symptom severity or functional impairment?
How do these hormonal patterns change over the course of illness, and could they serve as outcome measures for treatment response?
What This Study Does Not Prove
This study does not establish that hormonal imbalance causes ME/CFS—only that differences exist. It cannot determine whether hormone dysregulation is a primary driver of symptoms or a consequence of the illness. The cross-sectional design means researchers measured hormones at one point in time, so they cannot assess how these patterns change over the course of illness or treatment.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only